Texas Trainer Toby Keeton's Penalty Skyrockets to 64 Years, $535,000 Fine

Toby Keeton posted the richest single-season earnings total in American Quarter-Horse history in 2024. Fourteen months later, Texas interim executive director David Holmes quadrupled his suspension to 64 years and raised his fine to $535,000 in an amended order that amounts to a career death sentence for one of the sport's most prolific trainers.

The original Texas Racing Commission ruling, dated March 26, had already landed as one of the harsher medication sanctions in recent U.S. Quarter-Horse history: a 16-year suspension retroactive to January 30, 2025, and an $80,000 fine tied to 22 positive tests for carmoterol during the 2024 Lone Star Park fall meet. Holmes reviewed the case after that ruling was published and issued the amended order on April 2 with substantially heavier terms across every measure.

The authority Holmes invoked comes directly from Texas Racing Commission rules, which permit the executive director to modify rulings "where the penalties available to the stewards or judges are insufficient to adequately address the violation." In this case, Holmes determined the original penalty fell well short. The amended ruling also refined the full scope of the violation: 22 carmoterol positives came from 17 different horses across seven race dates, with violations spanning September 7 through November 16, plus a 23rd horse that returned a positive for d-methamphetamine, a second Class 1A substance.

Holmes' written justification put the standard bluntly: "Twenty-two Class 1A violations involving seventeen different horses across seven race dates is an extraordinary number of violations in a single ruling. This is not a case of a single inadvertent exposure. Prolific cheating does not deserve discounted penalties." He also flagged that carmoterol, a beta-agonist bronchodilator prohibited under Texas Racing Commission rules, had never previously been detected in horse racing anywhere, making the Keeton case a first of its kind in the substance's regulatory history.

Keeton has a five-calendar-day window to appeal the amended order. If that window closes without action, the suspension runs through January 30, 2089. The 64-year term is already accruing: Keeton has not saddled a starter since December 20, 2024, and the Texas commission summarily suspended him in January 2025. New Mexico, which had already reciprocated Texas' summary suspension, is now positioned to mirror the amended order. Keeton's horses also tested positive for carmoterol in that state, including during the All American Futurity at Downs at Albuquerque on September 2, a development that could generate separate state-level proceedings on top of the Texas penalties.

The purse redistribution tied to 22 or more disqualified races carries significant financial exposure for Keeton and, potentially, for owners whose horses competed in those events. Under the Texas Racing Act, possession of a prohibited substance with intent to influence a race can rise to the level of a felony, a threshold the commission's finding of systemic, intentional violations keeps firmly in view.

Keeton's career numbers put the stakes in relief: 136 wins from 438 starts at a 31 percent clip in 2024 alone, with $28.9 million in lifetime earnings. Whether the amended penalties survive what promises to be a vigorous legal challenge will determine how far Texas, and the jurisdictions watching it, are willing to push the outer limits of medication enforcement in Quarter-Horse racing.